The Antifibrotic Effects of Eplerenone in Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Papapostolou S, Iles L, O'Brien J, Gutman SJ, Ellims A, Hare J, Stub D, Moir S, Taylor AJ. The Antifibrotic Effects of Eplerenone in Hypertrophic Cardiomyopathy: A Randomized Clinical Trial. JACC Heart Fail. 2025 Jul; 13(7):102415.

View in: PubMed

subject areas

Adult
Aged
Cardiomyopathy, Hypertrophic
Diastole
Double-Blind Method
Female
Fibrosis
Humans
Magnetic Resonance Imaging, Cine
Male
Middle Aged
Myocardium
Spironolactone
Treatment Outcome

authors with profiles

Andrew Taylor, Ph.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support